Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide for Cardioprotection During CABG with CPB
NCT03500783Phase 2Completed
- Sponsor
- Tomsk National Research Medical Centre of the Russian Academy of Sciences
- Start
- May 2015
- Primary completion
- Nov 2016
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
01
Overview
A Phase 2 trial of nitric oxide in reperfusion injury (IRI), sponsored by Tomsk National Research Medical Centre of the Russian Academy of Sciences. Started May 2015; status: completed.
02
Drugs
nitric oxide
03
Conditions
reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT03500783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03500783.